Literature DB >> 29023126

Lyotropic Liquid-Crystalline Nanosystems as Drug Delivery Agents for 5-Fluorouracil: Structure and Cytotoxicity.

Paola Astolfi1, Elisabetta Giorgini2, Valentina Gambini3, Barbara Rossi4, Lisa Vaccari4, Francesco Vita1, Oriano Francescangeli1, Cristina Marchini3, Michela Pisani1.   

Abstract

Lyotropic cubic liquid-crystalline systems have received increasing attention due to their unique microstructural and physicochemical properties as efficient nanocarriers for drug delivery. We report the preparation and characterization of bulk phases and cubosome dispersions of phytantriol loaded with the anticancer drug 5-fluorouracil, in neutral and anionic forms. In both cases, a Pn3m cubic phase was observed. The phytantriol phase behavior can be influenced by the addition of ionic agents, and, to this purpose, a positively charged lipid, such as N-[1-(2,3-dioleoyloxy)propyl]-N,N,N-trimethylammonium chloride salt (DOTAP), was included in the studied formulations. It was found to induce a variation of the spontaneous membrane curvature of the phytantriol lipid bilayer, generating a transition from the Pn3m to the Im3m cubic phase. When 5-fluorouracil, in its anionic form (5-FUs), was encapsulated in these latter systems, a further transition to the HII hexagonal phase was observed as a consequence of the formation of a complex phytantriol/DOTAP/5-FUs. The physicochemical characterization was performed with various complementary techniques including synchrotron small-angle X-ray scattering, dynamic light scattering, and attenuated total reflection Fourier transform infrared and UV resonance Raman spectroscopies. Encapsulation of 5-fluorouracil in the corresponding nanodispersions was evaluated, and their in vitro cytotoxicity was assessed in MDA-MB-231 cell line. Phytantriol cubosomes containing 5-fluorouracil showed a higher toxicity compared with the bare drug solution, and hence they represent potential nanocarriers in the delivery of 5-fluorouracil for cancer therapy.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29023126     DOI: 10.1021/acs.langmuir.7b03173

Source DB:  PubMed          Journal:  Langmuir        ISSN: 0743-7463            Impact factor:   3.882


  8 in total

Review 1.  Cubosomes: The Next Generation of Smart Lipid Nanoparticles?

Authors:  Hanna M G Barriga; Margaret N Holme; Molly M Stevens
Journal:  Angew Chem Int Ed Engl       Date:  2018-09-26       Impact factor: 15.336

2.  Preparation, Synergism, and Biocompatibility of in situ Liquid Crystals Loaded with Sinomenine and 5-Fluorouracil for Treatment of Liver Cancer.

Authors:  Jiaojiao Cao; Jie Huang; Shuangying Gui; Xiaoqin Chu
Journal:  Int J Nanomedicine       Date:  2021-05-31

3.  Enhanced antitumor efficacy in colon cancer using EGF functionalized PLGA nanoparticles loaded with 5-Fluorouracil and perfluorocarbon.

Authors:  Pingping Wu; Qing Zhou; Huayun Zhu; Yan Zhuang; Jun Bao
Journal:  BMC Cancer       Date:  2020-04-28       Impact factor: 4.430

4.  Synchrotron Characterization of Hexagonal and Cubic Lipidic Phases Loaded with Azolate/Phosphane Gold(I) Compounds: A New Approach to the Uploading of Gold(I)-Based Drugs.

Authors:  Paola Astolfi; Michela Pisani; Elisabetta Giorgini; Barbara Rossi; Alessandro Damin; Francesco Vita; Oriano Francescangeli; Lorenzo Luciani; Rossana Galassi
Journal:  Nanomaterials (Basel)       Date:  2020-09-16       Impact factor: 5.076

5.  Sorafenib and triptolide loaded cancer cell-platelet hybrid membrane-camouflaged liquid crystalline lipid nanoparticles for the treatment of hepatocellular carcinoma.

Authors:  Zhe Li; Gang Yang; Lu Han; Rong Wang; Chunai Gong; Yongfang Yuan
Journal:  J Nanobiotechnology       Date:  2021-11-08       Impact factor: 10.435

6.  Identification and validation of a seven-gene prognostic marker in colon cancer based on single-cell transcriptome analysis.

Authors:  Yang Zhou; Yang Guo; Yuanhe Wang
Journal:  IET Syst Biol       Date:  2022-04       Impact factor: 1.615

Review 7.  Lyotropic Liquid Crystalline Nanostructures as Drug Delivery Systems and Vaccine Platforms.

Authors:  Maria Chountoulesi; Stergios Pispas; Ioulia K Tseti; Costas Demetzos
Journal:  Pharmaceuticals (Basel)       Date:  2022-03-31

Review 8.  Development, Therapeutic Evaluation and Theranostic Applications of Cubosomes on Cancers: An Updated Review.

Authors:  Yosif Almoshari
Journal:  Pharmaceutics       Date:  2022-03-09       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.